Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2

Sameh S.M. Soliman*, Alshaimaa M. Hamoda, Yogendra Nayak, Ahmed Mostafa, Rania Hamdy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science